Cytopia begins Second Phase II Study in Brain Cancer - Quick Facts (Nasdaq)

(RTTNews) - Cytopia Ltd. (CYTPF.PK, CYT.AX) announced that it has commenced enrolment for its phase Ib/II study of CYT997, in brain cancer known as glioblastoma multiforme.

Read full post here. Copyright (c) 2004 Yahoo! Inc. All rights reserved.

Related keywords: concept mapinformation skills, mindmapping

More articles:
Effective Reading Strategies
Actually, it’s not just our decision….
Study Guides, Practice Exams, Audio Trainer, and Exam Vouchers